ARTICLE | Clinical News
Thymectacin: Phase I
November 25, 2002 8:00 AM UTC
Preliminary results from a U.S. Phase I trial in 24 patients with advanced colorectal cancer that failed standard chemotherapy showed Thymectacin was well tolerated at all dose levels from 200-2,000 ...